The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin

Hompes, Daphne;D'Hoore, André;Van Cutsem, Eric;Fieuws, Steffen;Kerger, Joseph;et.al.
(2012) Annals of Surgical Oncology — Vol. 19, n° 7, p. 2186-2194 (2012)

Files

Hompes-2012-Thetreatmentofperitoneal.pdf
  • Restricted Access
  • Adobe PDF
  • 280.81 KB
Request a copy

Details

Authors
  • Hompes, Daphne
    Author
  • D'Hoore, André
    Author
  • Van Cutsem, Eric
    Author
  • Fieuws, Steffen
    Author
  • Claude, BertrandUCLouvain
    Author
  • Legendre, HuguesUCLouvain
    Author
  • Kerger, JosephUCLouvain
    Author
Show more
Abstract
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis (PC) as the only site of metastases. Complete cytoreductive surgery (CCRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) aims for locoregional disease control and long-term survival. Oxaliplatin is effective for treating advanced CRC. This study assesses the safety and efficacy of CCRS with HIPEC with oxaliplatin for patients with PC of CRC.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hompes, D., D’Hoore, A., Van Cutsem, E., Fieuws, S., Ceelen, W., Peeters, M., Van der Speeten, K., Claude, B., Legendre, H., & Kerger, J. (2012). The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin. Annals of Surgical Oncology, 19(7), 2186-2194. https://doi.org/10.1245/s10434-012-2264-z (Original work published 2012)